title: Combination therapy with InsB9-23 peptide immunization and CTLA4-IgG does not reverse diabetes in NOD mice.
authors.forename: Darius A
authors.initials: DA
authors.lastname: Schneider
authors.forename: Ghanashyam
authors.initials: G
authors.lastname: Sarikonda
authors.forename: Matthias G
authors.initials: MG
authors.lastname: von Herrath
mesh_terms: D000069594:Abatacept; D000818:Animals; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000628:therapy*; D007114:Immunization; D018796:Immunoconjugates / Q000276:immunology* / Q000627:therapeutic use; D051379:Mice; D016688:Mice, Inbred NOD; D010455:Peptides / Q000276:immunology*
chemical_list: D018796:Immunoconjugates; C571239:InsB9-23 peptide; D010455:Peptides; D000069594:Abatacept